Abstract
Synthetic biology aims to bring to biology the principles of engineering, standardizing and modularizing the design of biological systems to make possible the development of biological systems that perform specified tasks. Several distinct lines of research fall under the general heading of synthetic biology. Examples of synthetic biology to date include the development of microorganisms that can produce a precursor to artemisinin (a drug for treating malaria) and fuels. The technology poses ethical and policy challenges concerning its risks and potential benefits, its socioeconomic impact and the implications for social justice, and the very idea of engineering living organisms. Many commentators have recommended that these questions should be addressed in a manner that engages the public, raising additional questions about how that is best done.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
BioBricks Foundation. (2011). http://biobricks.org
Boldt, J., & Müller, O. (2008). Newtons of the leaves of grass. Nature Biotechnology, 26, 387–389.
Brent, R. (2004). A partnership between biology and engineering. Nature Biotechnology, 22, 1211–1214.
Campos, L. (2009). That was the synthetic biology that was. In M. Schmidt, A. Kelle, A. Ganguli-Mitra, & H. de Vriend (Eds.), Synthetic biology: The technoscience and its social consequences (pp. 5–22). Dordrecht: Springer.
Caplan, A. (2010). Now ain’t that special? The implications of creating the first synthetic bacteria. Guest Blog, hosted by Scientific American, May 20, 2010. http://www.scientificamerican.com/blog/post.cfm?id=now-aint-that-special-the-implicati-2010-05-20
Caruso, D. (2008). Synthetic biology: An overview and recommendations for anticipating and addressing emerging risks. Washington, DC: Center for American Progress.
Cello, J., Paul, A. V., & Wimmer, E. (2002). Chemical synthesis of poliovirus cDNA: Generation of infectious virus in the absence of natural template. Science, 297, 1016–1018.
Cho, M. K., Magnus, D., Caplan, A. L., McGee, D., & The Ethics of Genomics Group. (1999). Ethical considerations in synthesizing a minimal genome. Science, 286, 2087–2090.
ETC Group. (2007). Extreme genetic engineering: An introduction to synthetic biology. Ottawa, ON: The ETC Group.
ETC Group. (2010). The new biomassters: Synthetic biology and the next assault on biodiversity and livelihoods. Ottawa, ON: The ETC Group.
Garfinkel, M. S., Endy, D., Epstein, G. L., & Friedman, R. M. (2007). Synthetic genomics: Options for governance. Rockville, MD: J. Craig Venter Institute.
Gibson, D. G., Benders, G. A., Andrews-Pfannkoch, C., Denisova, E. A., Baden-Tillson, H., Zaveri, J., et al. (2008). Complete chemical synthesis, assembly, and cloning of a Mycoplasma genitalium genome. Science, 319, 1215–1220.
Gibson, D. G., Glass, J. I., Lartigue, C., Noskov, V. N., Chuang, R. Y., Algire, M. A., et al. (2010). Creation of a bacterial cell controlled by a chemically synthesized genome. Science, 329, 52–56.
Hale, V., Keasling, J. D., Renninger, N., & Diagana, T. T. (2007). Microbially derived artemisinin: A biotechnology solution to the global problem of access to affordable antimalarial drugs. The American Journal of Tropical Medicine and Hygiene, 77(Supple 6), 198–202.
iGEM. (2010). http://2010.igem.org
Jang, Y.-S., Park, J. M., Choi, S., Choi, Y. J., Seung, D. Y., Cho, J. H., et al. (2012). Engineering of microorganisms for the production of biofuels and perspectives based on systems metabolic engineering approaches. Biotechnology Advances, 30(5), 989–1000.
Kwok, R. (2010). Five hard truths for synthetic biology. Nature, 463, 288–290.
BBC Monitoring Europe. (2010). Vatican dismisses synthetic cell’s life-giving dimensions, lauds science research. May 25, 2010.
Mukunda, G., Oye, K. A., & Mohr, S. C. (2009). What rough beast? Synthetic biology, uncertainty, and the future of biosecurity. Politics and the Life Sciences, 28(2), 2–26.
Nielsen, J., & Kiesling, J. (2011). Synergies between synthetic biology and metabolic engineering. Nature Biotechnology, 29, 693–695.
O'Malley, M. A., Powell, A., Davies, J. F., & Calvert, J. (2008). Knowledge-making distinctions in synthetic biology. BioEssays, 30, 57–65.
Presidential Commission for the Study of Bioethical Issues. (2010). New directions: The ethics of synthetic biology and emerging technologies. Washington, DC: U.S. Government Printing Office.
Sachs, J. S. (2007). Good germs, bad germs: Health and survival in a bacterial world. New York: Hill and Wang.
Snow, A. (2011). Testimony to the presidential commission for the study of bioethical issues, July 8–9, 2011, Washington, DC. http://bioethics.gov/cms/meeting-one-transcripts
Specter, M. (2009, September). A life of its own: Where will synthetic biology lead us? The New Yorker. 56–65
Tumpey, T. M., Basler, C. F., Aguilar, P. V., Zeng, H., Solorzano, A., Swaynev, D. E., et al. (2005). Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science, 310, 77–80.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media Dordrecht
About this entry
Cite this entry
Kaebnick, G.E. (2014). Synthetic Biology. In: ten Have, H., Gordijn, B. (eds) Handbook of Global Bioethics. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-2512-6_135
Download citation
DOI: https://doi.org/10.1007/978-94-007-2512-6_135
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-2511-9
Online ISBN: 978-94-007-2512-6
eBook Packages: Humanities, Social Sciences and Law